BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 29502671)

  • 1. Discussion of: Is there a role for Ytrrium-90 in the treatment of unresectable and metastatic intrahepatic cholangiocarcinoma?
    Am J Surg; 2018 Mar; 215(3):471. PubMed ID: 29502671
    [No Abstract]   [Full Text] [Related]  

  • 2. Is there a role for Ytrrium-90 in the treatment of unresectable and metastatic intrahepatic cholangiocarcinoma?
    Shaker TM; Chung C; Varma MK; Doherty MG; Wolf AM; Chung MH; Assifi MM
    Am J Surg; 2018 Mar; 215(3):467-470. PubMed ID: 29395023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Unresectable intrahepatic cholangiocarcinoma: 50 % resectability after neoadjuvant therapy].
    Strobel O; Büchler MW
    Chirurg; 2019 Mar; 90(Suppl 2):70. PubMed ID: 30758552
    [No Abstract]   [Full Text] [Related]  

  • 4. Growing Evidence Supports the Use of Radiation Therapy in Unresectable Intrahepatic Cholangiocarcinoma.
    Cuneo KC; Lawrence TS
    Cancer J; 2016; 22(4):243-4. PubMed ID: 27441742
    [No Abstract]   [Full Text] [Related]  

  • 5. [Unresectable intrahepatic cholangiocarcinoma: 50 % resectability after neoadjuvant therapy].
    Strobel O; Büchler MW
    Chirurg; 2018 Mar; 89(3):241. PubMed ID: 29387900
    [No Abstract]   [Full Text] [Related]  

  • 6. Consideration of the role of radiotherapy for unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 75 patients.
    Zeng ZC; Tang ZY; Fan J; Zhou J; Qin LX; Ye SL; Sun HC; Wang BL; Li D; Wang JH; Zeng MS; Guo W; Tan YS
    Cancer J; 2006; 12(2):113-22. PubMed ID: 16630402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transarterial chemoembolization versus supportive therapy in the palliative treatment of unresectable intrahepatic cholangiocarcinoma.
    Park SY; Kim JH; Yoon HJ; Lee IS; Yoon HK; Kim KP
    Clin Radiol; 2011 Apr; 66(4):322-8. PubMed ID: 21356394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histopathology of a benign bile duct lesion in the liver: Morphologic mimicker or precursor of intrahepatic cholangiocarcinoma.
    Lee KB
    Clin Mol Hepatol; 2016 Sep; 22(3):400-405. PubMed ID: 27729636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Progress on surgical treatment of intrahepatic cholangiocarcinoma].
    Shen F; Xie ZH; Xia Y; Wu MC
    Zhonghua Wai Ke Za Zhi; 2019 Apr; 57(4):241-246. PubMed ID: 30929367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocellular cancer, cholangiocarcinoma, and metastatic tumors of the liver.
    Wagman LD
    Surg Oncol Clin N Am; 2015 Jan; 24(1):xiii-xiv. PubMed ID: 25444478
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatocellular cancer, cholangiocarcinoma, and metastatic tumors of the liver.
    Petrelli NJ
    Surg Oncol Clin N Am; 2015 Jan; 24(1):xi-xii. PubMed ID: 25444477
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatic arterial infusion of mitomycin C with degradable starch microspheres for unresectable intrahepatic cholangiocarcinoma.
    Shitara K; Ikami I; Munakata M; Muto O; Sakata Y
    Clin Oncol (R Coll Radiol); 2008 Apr; 20(3):241-6. PubMed ID: 18222071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is resection for solitary ≤5 cm intrahepatic cholangiocarcinoma an independent prognostic factor for survival?
    Tsai AJ
    Surgery; 2019 Apr; 165(4):853-858. PubMed ID: 30055790
    [No Abstract]   [Full Text] [Related]  

  • 14. ["EXTENDED" RIGHT HEPATECTOMY FOR PRIMARY CHOLANGIOCARCINOMA OF THE LIVER].
    VANWIEN A; COLARD M; GODART J; PLATTEBORSE R
    Acta Chir Belg; 1964 Oct; 63():725-8. PubMed ID: 14248934
    [No Abstract]   [Full Text] [Related]  

  • 15. Imaging approach to hepatocellular carcinoma, cholangiocarcinoma, and metastatic colorectal cancer.
    Fowler KJ; Saad NE; Linehan D
    Surg Oncol Clin N Am; 2015 Jan; 24(1):19-40. PubMed ID: 25444467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective intrahepatic duct cannulation by using a triple-lumen catheter for endoscopic bilateral stenting in hilar cholangiocarcinoma.
    Kim JY; Kang DH; Choi CW; Kim HW; Park SB; Kim DU
    Gastrointest Endosc; 2010 Jul; 72(1):192-8. PubMed ID: 20546732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrahepatic cholangiocarcinoma--a rare indication for liver transplantation. Case report and review of the literature.
    Hrehoreţ D; Alexandrescu S; Grigorie R; Herlea V; Anghel R; Popescu I
    Chirurgia (Bucur); 2012; 107(2):237-42. PubMed ID: 22712355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation of two subtypes of intrahepatic cholangiocarcinoma: imaging approach.
    Yoshimitsu K
    Eur Radiol; 2019 Jun; 29(6):3108-3110. PubMed ID: 30915566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management and extent of resection for intrahepatic cholangiocarcinoma.
    Carpizo DR; D'Angelica M
    Surg Oncol Clin N Am; 2009 Apr; 18(2):289-305, viii-ix. PubMed ID: 19306813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of tenascin, type IV collagen and laminin during human intrahepatic bile duct development and in intrahepatic cholangiocarcinoma.
    Terada T; Nakanuma Y
    Histopathology; 1994 Aug; 25(2):143-50. PubMed ID: 7527010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.